TME Clinical Trials

671 recruitingLast updated: May 21, 2026

There are 671 actively recruiting tme clinical trials across 55 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1, Early Phase 1. Top locations include Tianjin, Tianjin Municipality, China, New York, New York, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


TME Trials at a Glance

671 actively recruiting trials for tme are listed on ClinicalTrialsFinder across 6 cities in 55 countries. The largest study group is Not Applicable with 297 trials, with the heaviest enrollment activity in Tianjin, New York, and Boston. Lead sponsors running tme studies include Institute of Hematology & Blood Diseases Hospital, China, Centre for Addiction and Mental Health, and Shanghai Juncell Therapeutics.

About TME Clinical Trials

Looking for clinical trials for TME? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new TME trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about TME clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 671 trials

Recruiting

Exploration of the Utility of Dental-dedicated MRI for Dentistry

orthodonticsDental CrowdingEndodontic Disease+5 more
University of Minnesota300 enrolled1 locationNCT06948162
Recruiting
Not Applicable

Acute Impact of Whey Protein-enriched Milk Fat Globule Membrane Supplementation on Postprandial Markers of Heart and Brain Health

Cardiovascular DiseasesCardiometabolic Risk FactorsCognition+2 more
Loughborough University16 enrolled1 locationNCT06953232
Recruiting
Not Applicable

Implementing Depression and Adherence Treatment

DepressionHIVAdherence, Treatment+1 more
University of Miami10 enrolled3 locationsNCT07032363
Recruiting
Not Applicable

Diagnosing Epilepsy To EffeCT Change

EpilepsyEpilepsy (Treatment Refractory)
Epiminder America, Inc.210 enrolled17 locationsNCT07110337
Recruiting

Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

EpilepsyEpilepsy (Treatment Refractory)
Epiminder America, Inc.210 enrolled12 locationsNCT07110454
Recruiting
Not Applicable

Sana Device for Post-Treatment Lyme Disease Syndrome Chronic Pain

Chronic PainPost-treatment Lyme Disease Syndrome
Icahn School of Medicine at Mount Sinai20 enrolled1 locationNCT06655844
Recruiting
Not Applicable

Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama

HIVHIV TreatmentHIV Testing+1 more
University of Alabama at Birmingham80 enrolled1 locationNCT05384145
Recruiting
Phase 1

Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors

Advanced Solid TumorAdvanced Solid Tumors Appropriate for Treatment With Either Nivolumab or Pembrolizumab
Vaxiion Therapeutics48 enrolled7 locationsNCT05901285
Recruiting

Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START

Rural HealthSubstance Use Disorder (SUD)Child Maltreatment+3 more
Ohio State University400 enrolled1 locationNCT07278427
Recruiting

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

Postmenopausal Bleeding
University of Aarhus600 enrolled3 locationsNCT07400835
Recruiting
Phase 3

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Acute Treatment of Migraine
Pfizer600 enrolled126 locationsNCT04743141
Recruiting
Not Applicable

An Emergency Department (ED) Provider Centered Intervention for Non-Traumatic Dental Condition Management (NTDC)

Emergency Department VisitOdontalgia
University of Florida60 enrolled1 locationNCT06330207
Recruiting
Not Applicable

REsults of LOw Anterior Resections With or Without Preventive Stoma in Nonemergency Department

Rectal Cancer SurgeryTMEMiddle Rectal Cancer+2 more
ANO Scientific and Practical Club for the Development of Modern Medical Technologies442 enrolled7 locationsNCT07463261
Recruiting
Phase 1Phase 2

Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML

TreatmentAMLIDH1 Mutation
Institute of Hematology & Blood Diseases Hospital, China23 enrolled1 locationNCT06611839
Recruiting
Not Applicable

Treatment of Lower Leg Anterolateral Chronic Exertional Compartment Syndrome With Intra-muscular Botulinum Injections.

Chronic Exertional Compartment Syndrome
University of Calgary50 enrolled1 locationNCT05765071
Recruiting
Phase 2

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Treatment Resistant Depression
atai Therapeutics, Inc.142 enrolled48 locationsNCT06524830
Recruiting
Not Applicable

Health Care Transition Readiness Short-Form Video Intervention

emotional wellbeingSelf EfficacyHealth Literacy+2 more
Children's Hospital Los Angeles44 enrolled1 locationNCT06842576
Recruiting

Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer

Esophageal CancerNeoadjuvant TreatmentMalnourished+1 more
University Hospital, Bordeaux670 enrolled1 locationNCT07584577
Recruiting
Phase 1

Restoration of Antibiotics Related Infant Microbiota Perturbations by Autologous Fecal Transplant

Antibiotic Treatment
Rutgers, The State University of New Jersey100 enrolled1 locationNCT06609980
Recruiting
Phase 4

A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

Depressive Disorder, Treatment-Resistant
Janssen Korea, Ltd., Korea47 enrolled6 locationsNCT07053345